These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 1621407

  • 1. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A, Herrmann G, Gerdesmeyer L, Simon R.
    Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
    [Abstract] [Full Text] [Related]

  • 2. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A, Schmelzle T, Simon R.
    Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
    [Abstract] [Full Text] [Related]

  • 3. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 4. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
    Mager G, Klocke RK, Volkmann A, Kux A, Höpp HW, Hilger HH.
    Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
    [Abstract] [Full Text] [Related]

  • 5. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
    Domínguez de Rozas JM, Guindo Soldevila J, Rodríguez Font E, Martínez Vílchez R.
    Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
    [Abstract] [Full Text] [Related]

  • 6. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
    Monrad ES, Baim DS, Smith HS, Lanoue AS.
    Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
    [Abstract] [Full Text] [Related]

  • 7. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
    Pflugfelder PW, O'Neill BJ, Ogilvie RI, Beanlands DS, Tanser PH, Tihal H, Mizgala HF, Fitchett DH, Kostuk WJ.
    Can J Cardiol; 1991 Mar; 7(1):5-10. PubMed ID: 2025794
    [Abstract] [Full Text] [Related]

  • 8. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
    Boesch C, Dubois-Rande JL, Pochmalicki G, Lellouche D, Teiger E, Saal JP, Cachin JC, Mallo C, Castaigne A, Jan F.
    Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
    [Abstract] [Full Text] [Related]

  • 9. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES, Baim DS, Smith HS, Lanoue AS, Silverman KJ, Gervino EV, Grossman W.
    Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [Abstract] [Full Text] [Related]

  • 10. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 11. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V, Neuzner J, Opper H, Thormann J, Schlepper M.
    Z Kardiol; 1994 Dec; 83 Suppl 2():37-48. PubMed ID: 8091823
    [Abstract] [Full Text] [Related]

  • 12. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P, Ramaprasad S.
    Pharmacotherapy; 1997 Dec; 17(2):371-4. PubMed ID: 9085331
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery.
    Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial Group.
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):306-15. PubMed ID: 11426360
    [Abstract] [Full Text] [Related]

  • 14. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L, Bottero M, Centofante P, Bedogni F, Ometto R, Cera A, Fortunato A.
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [Abstract] [Full Text] [Related]

  • 15. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 16. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM, Pugh S, Noble MI.
    Clin Ther; 1994 Jun; 16(5):783-92. PubMed ID: 7859237
    [Abstract] [Full Text] [Related]

  • 17. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
    Gun C, Piegas LS, Bianco AC, Freire RB, Ramos RF, Timerman A.
    Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
    [Abstract] [Full Text] [Related]

  • 18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 19. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
    Mager G, Steffen HM, Klocke RK, Wambach G, Kux A, Degenhardt S, Höpp HW, Hilger HH.
    Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668
    [Abstract] [Full Text] [Related]

  • 20. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
    Galinier M, Rochiccioli JP, Edouard P, Fourcade J, Massabuau P, Puel J, Fauvel JM, Bounhoure JP.
    Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.